Medtronic, a medical technology company, and Fitbit, a player in the connected health and fitness market, disclosed Wednesday a partnership to integrate health and activity tracking for patients living with diabetes and their physicians and care teams.
The companies said in a joint statement the iPro2 myLog mobile app will allow patients living with type 2 diabetes to see their glucose levels and physical activity data in one streamlined application.
“We believe the integration of wearable technology with professional diagnostic tools can provide a more accurate and actionable view of a patient’s physical activity,” said Adam Pellegrini, vice president of Digital Health for Fitbit.
Like heart monitors and other clinical trackers, the iPro2 Professional CGM system records a patient’s glucose levels 24 hours a day for up to six days.
By Stephen Holmes